By-health Co., Ltd. (300146.SZ)
CNY 12.76
(-0.39%)
CNY 12.76
(-0.39%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.46 Billion CNY | 16.06% |
| 2022 | 5.36 Billion CNY | 9.34% |
| 2021 | 4.9 Billion CNY | 28.23% |
| 2020 | 3.82 Billion CNY | 10.62% |
| 2019 | 3.46 Billion CNY | 17.57% |
| 2018 | 2.94 Billion CNY | 41.08% |
| 2017 | 2.08 Billion CNY | 40.32% |
| 2016 | 1.48 Billion CNY | -0.99% |
| 2015 | 1.5 Billion CNY | 33.5% |
| 2014 | 1.12 Billion CNY | 17.31% |
| 2013 | 958.96 Million CNY | 41.86% |
| 2012 | 675.99 Million CNY | 60.13% |
| 2011 | 422.14 Million CNY | 89.21% |
| 2010 | 223.11 Million CNY | 71.94% |
| 2009 | 129.76 Million CNY | 51.71% |
| 2008 | 85.53 Million CNY | 137.22% |
| 2007 | 36.05 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 731.71 Million CNY | -41.66% |
| 2024 Q1 | 1.83 Billion CNY | 84.1% |
| 2024 Q2 | 1.25 Billion CNY | -31.76% |
| 2023 Q3 | 1.48 Billion CNY | -15.09% |
| 2023 Q1 | 2.18 Billion CNY | 93.23% |
| 2023 Q2 | 1.74 Billion CNY | -19.95% |
| 2023 FY | 6.23 Billion CNY | 16.06% |
| 2023 Q4 | 998.33 Million CNY | -32.8% |
| 2022 Q3 | 1.3 Billion CNY | -2.24% |
| 2022 Q2 | 1.33 Billion CNY | -15.59% |
| 2022 Q1 | 1.58 Billion CNY | 79.73% |
| 2022 FY | 5.36 Billion CNY | 9.34% |
| 2022 Q4 | 1.13 Billion CNY | -13.65% |
| 2021 Q2 | 1.32 Billion CNY | -10.99% |
| 2021 Q1 | 1.48 Billion CNY | 177.08% |
| 2021 FY | 4.9 Billion CNY | 28.23% |
| 2021 Q4 | 883.16 Million CNY | -27.4% |
| 2021 Q3 | 1.21 Billion CNY | -8.07% |
| 2020 Q1 | 1 Billion CNY | 96.82% |
| 2020 Q4 | 536.52 Million CNY | -56.92% |
| 2020 Q3 | 1.24 Billion CNY | 19.85% |
| 2020 FY | 3.82 Billion CNY | 10.62% |
| 2020 Q2 | 1.03 Billion CNY | 3.17% |
| 2019 Q1 | 1.05 Billion CNY | 82.26% |
| 2019 Q3 | 929.56 Million CNY | -3.53% |
| 2019 FY | 3.46 Billion CNY | 17.57% |
| 2019 Q4 | 511.78 Million CNY | -44.94% |
| 2019 Q2 | 963.61 Million CNY | -8.76% |
| 2018 FY | 2.94 Billion CNY | 41.08% |
| 2018 Q2 | 779.56 Million CNY | 8.01% |
| 2018 Q1 | 721.75 Million CNY | 39.47% |
| 2018 Q3 | 863.06 Million CNY | 10.71% |
| 2018 Q4 | 579.47 Million CNY | -32.86% |
| 2017 Q3 | 574.24 Million CNY | 11.09% |
| 2017 Q4 | 517.48 Million CNY | -9.88% |
| 2017 FY | 2.08 Billion CNY | 40.32% |
| 2017 Q1 | 477.99 Million CNY | 101.61% |
| 2017 Q2 | 516.92 Million CNY | 8.15% |
| 2016 Q3 | 445.27 Million CNY | 16.45% |
| 2016 Q4 | 237.08 Million CNY | -46.75% |
| 2016 FY | 1.48 Billion CNY | -0.99% |
| 2016 Q1 | 422.3 Million CNY | 33.43% |
| 2016 Q2 | 382.36 Million CNY | -9.46% |
| 2015 Q3 | 398.62 Million CNY | -3.21% |
| 2015 FY | 1.5 Billion CNY | 33.5% |
| 2015 Q4 | 316.5 Million CNY | -20.6% |
| 2015 Q2 | 411.85 Million CNY | 9.88% |
| 2015 Q1 | 374.84 Million CNY | 79.9% |
| 2014 Q4 | 208.36 Million CNY | -28.56% |
| 2014 Q2 | 312.32 Million CNY | -0.09% |
| 2014 Q3 | 291.67 Million CNY | -6.61% |
| 2014 FY | 1.12 Billion CNY | 17.31% |
| 2014 Q1 | 312.6 Million CNY | 50.91% |
| 2013 Q3 | 266.97 Million CNY | 6.77% |
| 2013 FY | 958.96 Million CNY | 41.86% |
| 2013 Q1 | 234.79 Million CNY | 43.64% |
| 2013 Q2 | 250.05 Million CNY | 6.5% |
| 2013 Q4 | 207.14 Million CNY | -22.41% |
| 2012 Q4 | 163.46 Million CNY | -7.0% |
| 2012 FY | 675.99 Million CNY | 60.13% |
| 2012 Q3 | 175.76 Million CNY | 13.72% |
| 2012 Q2 | 154.56 Million CNY | -15.16% |
| 2012 Q1 | 182.18 Million CNY | 55.71% |
| 2011 Q3 | 126.73 Million CNY | 32.92% |
| 2011 Q4 | 117 Million CNY | -7.68% |
| 2011 Q1 | 83.05 Million CNY | 36.08% |
| 2011 Q2 | 95.34 Million CNY | 14.8% |
| 2011 FY | 422.14 Million CNY | 89.21% |
| 2010 Q4 | 61.03 Million CNY | 2.0% |
| 2010 Q3 | 59.83 Million CNY | 23.2% |
| 2010 FY | 223.11 Million CNY | 71.94% |
| 2010 Q2 | 48.56 Million CNY | -9.51% |
| 2010 Q1 | 53.67 Million CNY | 44.74% |
| 2009 FY | 129.76 Million CNY | 51.71% |
| 2009 Q3 | 33.25 Million CNY | 0.0% |
| 2009 Q4 | 37.08 Million CNY | 11.52% |
| 2008 FY | 85.53 Million CNY | 137.22% |
| 2007 FY | 36.05 Million CNY | 0.0% |